Efficacy of two siddha polyherbal decoctions, Nilavembu Kudineer and Kaba Sura Kudineer, along with standard allopathy treatment in the management of mild to moderate symptomatic COVID-19 patients—a double-blind, placebo-controlled, clinical trial

Efficacy of two siddha polyherbal decoctions, Nilavembu Kudineer and Kaba Sura Kudineer, along with standard allopathy treatment in the management of mild to moderate symptomatic COVID-19 patients—a double-blind, placebo-controlled, clinical trial

Abstract Background and aim Globally, the ongoing pursuit in exploring an effective drug to combat severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) virus has not met with significant success to date. Indian traditional medicines, especially polyherbal formulations like Nilavembu Kudineer...

Full description

Bibliographic Details
Main Authors: Anurag Srivastava, Manickavasagam Rengaraju, Saurabh Srivastava, Vimal Narayanan, Vivek Gupta, Rashmi Upadhayay, Jitender Kumar, Sathiyarajeswaran Parameswaran, KanakavalliKadarkarai, AarthiVelmurugan
Format: Article
Language:English
Published: BMC 2021-08-01
Series:Trials
Subjects:
Mild to moderate COVID-19
Siddha medicine
Kaba Sura Kudineer
Nilavembu Kudineer
Double-blinded RCT
Online Access:https://doi.org/10.1186/s13063-021-05478-0

Internet

https://doi.org/10.1186/s13063-021-05478-0

Similar Items